At Merck, Dr. Paweletz successfully built platforms to look at disease biomarkers in body fluids and oversaw research activities spanning the spectrum from early‑stage discovery to the clinic.
Keiko Shinjo, MD, PhD, Associate Professor, Division of Cancer Biology, Nagoya University Graduate School of Medicine, Japan
Keiko Shinjo's research has been focused on the dynamic regulation of gene expression by epigenetic mechanisms in human cancers. She applied ddPCR technique to detect aberrant DNA methylation in circulating free DNA for diagnose cancer.
From March 2020, Sandi Deans has been part of the UK national COVID‑9 response team and is Head of Laboratory Validation and Quality Assurance for SARS‑CoV‑2 testing for mass testing.
Over the past years, Dr Soverini has cultivated a growing interest in the application of novel technologies as diagnostic tools.
Fernando Bastida is leading SARS‑CoV‑2 research in collaboration with scientist groups in Mexico to get better understanding of the COVID‑19 infection in qPCR negative cases, anti‑drug activity of some compounds and multi‑infection cases.
The example from SARS‑CoV‑2
Dr. Qiu has been leading the development of a variety of molecular diagnostic standards, such as COVID‑19 RNA reference material, IHC quantitative control, HRD reference standards etc., all of which have been developed with the collaboration of world‑class IVD companies to provide better solutions for quality control in clinical laboratory.
In 2020, Dr. Driscoll's group began testing wastewater on campus for the presence of SARS‑CoV‑2 using Droplet Digital PCR, and are currently expanding their efforts state‑wide.
Dr Chen is engaged in the research of replication and pathogenesis of medical viruses such as coronavirus and virus control, analyzing the functions and structures of SARS coronavirus RNA methyltransferase, main protease and N protein and their mechanisms of action, and developed four targeted anti-coronavirus inhibitors.
In this webinar, Dr. William Winter will discuss the nuances and pitfalls of HbA1c analysis, focusing on accurate measurement in the presence of hemoglobin variants, and share real-life examples for practical insights.
In this webinar, Dr. David Robertson will share valuable insights into HbA1c as a diagnostic test for diabetes; options available in choosing an HbA1c testing method; factors that affect HbA1c test results, and how these might impact patient care decisions.
